EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Urinary Glycopeptide Profile Differentiates Early Cardiorenal Risk in Subjects Not Meeting Criteria for Chronic Kidney Disease

Aranzazu Santiago-Hernandez, Marta Martin-Lorenzo iD, María Gómez-Serrano iD, Juan Antonio Lopez iD, Ariadna Martin-Blazquez iD, Perceval Vellosillo, Pablo Minguez iD, Paula J Martinez, Jesús Vázquez iD, Gema Ruiz-Hurtado iD, Maria G Barderas iD, Pantelis Sarafidis iD und 3 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25137005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Aranzazu Santiago-Hernandez und 14 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz-UAM, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Glycopeptides, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades, Comunidad de Madrid.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early diagnosis and treatment of chronic kidney disease (CKD) is a worldwide challenge. Subjects with albumin-to-creatinine ratio (ACR) ≥ 30 mg/g and preserved renal function are considered to be at no cardiorenal risk in clinical practice, but prospective clinical studies evidence increased risk, even at the high-normal (HN) ACR range (10–30 mg/g), supporting the need to identify other molecular indicators for early assessment of patients at higher risk. Following our previous studies, here we aim to stratify the normoalbuminuria range according to cardiorenal risk and identify the glycoproteins and N-glycosylation sites associated with kidney damage in subclinical CKD. Glycoproteins were analyzed in urine from hypertensive patients within the HN ACR range compared to control group (C; ACR < 10 mg/g) by mass spectrometry. A different cohort was analyzed for confirmation (ELISA) and sex perspective was evaluated. Patients’ follow-up for 8 years since basal urine collection revealed higher renal function decline and ACR progression for HN patients. Differential N-glycopeptides and their N -glycosylation sites were also identified, together with their pathogenicity. N-glycosylation may condition pathological protein deregulation, and a panel of 62 glycoproteins evidenced alteration in normoalbuminuric subjects within the HN range. Haptoglobin-related protein, haptoglobin, afamin, transferrin, and immunoglobulin heavy constant gamma 1 (IGHG1) and 2 (IGHG2) showed increased levels in HN patients, pointing to disturbed iron metabolism and tubular reabsorption and supporting the tubule as a target of interest in the early progression of CKD. When analyzed separately, haptoglobin, afamin, transferrin, and IGHG2 remained significant in HN, in both women and men. At the peptide level, 172 N-glycopeptides showed differential abundance in HN patients, and 26 showed high pathogenicity, 10 of them belonging to glycoproteins that do not show variation between HN and C groups. This study highlights the value of glycosylation in subjects not meeting KDIGO criteria for CKD. The identified N-glycopeptides and glycosylation sites showed novel targets, for both the early assessment of individual cardiorenal risk and for intervention aimed at anticipating CKD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycopeptidesRenal Insufficiency, ChronicHumansMaleFemaleMiddle AgedGlycosylationAgedBiomarkersCreatinineGlycoproteinsDisease ProgressionAlbuminuriaRisk FactorsHaptoglobins

Stichwörter der Autor:innen

N-glycosylationcardiorenal riskcardiovascular diseasechronic kidney diseaseglycoproteinshypertensionproteomics

Substanzen

GlycopeptidesBiomarkersCreatinineGlycoproteinsHaptoglobins

Autor:innen und Institutionen

  • Immunology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz-UAM, 28040 Madrid, Spain.
  • Fundación Jiménez Díaz University Hospital-UAM, 28040 Madrid, Spain.
  • Laboratory of Cardiovascular Proteomics, Centro Nacional de Investigaciones Cardiovasculares, 28029 Madrid, Spain.
  • Center for Tumor Biology and Immunology (ZTI), Philipps University, 35043 Marburg, Germany.
  • CIBER de Enfermedades Cardiovasculares (CIBERCV), 28041 Madrid, Spain.
  • Bioinformatics Unit, Genetics Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz-UAM, 28040 Madrid, Spain.

ORCID-Profile: Marta Martin-Lorenzo, María Gómez-Serrano, Juan Antonio Lopez, Ariadna Martin-Blazquez, Pablo Minguez, Jesús Vázquez, Gema Ruiz-Hurtado, Maria G Barderas, Pantelis Sarafidis, Julian Segura, Gloria Alvarez-Llamas

Förderung

  • Instituto de Salud Carlos III
  • Ministerio de Ciencia, Innovación y Universidades
  • Comunidad de Madrid
  • Fundación SENEFRO/SEN
  • Fundación Mutua Madrileña
  • La Caixa Banking Foundation
  • Fundación Conchita Rábago
  • Spanish Ministry of Science, Innovation, and Universities

Zitieren

APA

Santiago-Hernandez, A., Martin-Lorenzo, M., Gómez-Serrano, M., Lopez, J. A., Martin-Blazquez, A., Vellosillo, P., Minguez, P., Martinez, P. J., Vázquez, J., Ruiz-Hurtado, G., Barderas, M. G., Sarafidis, P., Segura, J., Ruilope, L. M., & Alvarez-Llamas, G. (2024). The Urinary Glycopeptide Profile Differentiates Early Cardiorenal Risk in Subjects Not Meeting Criteria for Chronic Kidney Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137005

Vancouver

Santiago-Hernandez A, Martin-Lorenzo M, Gómez-Serrano M, Lopez JA, Martin-Blazquez A, Vellosillo P, et al. The Urinary Glycopeptide Profile Differentiates Early Cardiorenal Risk in Subjects Not Meeting Criteria for Chronic Kidney Disease. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137005

BibTeX
@article{SantiagoHernandez2024,
  author = {Santiago-Hernandez, Aranzazu and Martin-Lorenzo, Marta and Gómez-Serrano, María and Lopez, Juan Antonio and Martin-Blazquez, Ariadna and Vellosillo, Perceval and Minguez, Pablo and Martinez, Paula J and Vázquez, Jesús and Ruiz-Hurtado, Gema and Barderas, Maria G and Sarafidis, Pantelis and Segura, Julian and Ruilope, Luis M and Alvarez-Llamas, Gloria},
  title = {The Urinary Glycopeptide Profile Differentiates Early Cardiorenal Risk in Subjects Not Meeting Criteria for Chronic Kidney Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25137005}
}
Kostenlos starten →